Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 10,104 shares at $110.55 ($1.1M) on 2012-08-27, disclosed to the SEC on 2012-08-29.
Seasonal sale ($1.1M) by Executive VP U.S. Generics — this insider has traded PRGO in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.17 | 688 | $75K | 6.7% |
| 2 | $110.55 | 2,693 | $298K | 26.6% |
| 3 | $110.66 | 1,384 | $153K | 13.7% |
| 4 | $110.66 | 1,987 | $220K | 19.7% |
| 5 | $110.80 | 3,352 | $371K | 33.2% |
| Total | $110.58 avg | 10,104 |
| $1.1M |
| 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |